FARMINGTON, Conn., May 31, 2012 /PRNewswire-iReach/ -- BioInformant's two newest market researchs report offers mission-critical insight into the complex but lucrative world of embryonic stem cell product development and patent licensing. To promote these excellent products, Global Information Inc is offering our first 10 customers an Amazon Kindle Fire tablet with their purchase, as well as a copy of BioInformant's 2012 Marketing Database of Stem Cell Researchers, a combined $1500 value, absolutely free.
Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products
Companies interested in developing human embryonic stem cell products have to navigate a risky product environment. Due to the long-standing and controversial patents held by the University of Wisconsin's Alumni Research Foundation (WARF), companies have been largely hindered by the intellectual property (IP) environment restricting the development of embryonic stem cell products. However, going where competitors fear to tread means tremendous financial rewards are available for the companies that move boldly forward.
Human embryonic stem cells offer tremendous therapeutic potential, as they can develop into over 200 different cell types. However, up until now, WARF has had the power to largely control what companies can develop embryonic stem cell products and on what terms. With the release of BioInformant's report Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products, published June 2012, research supply companies can now receive clear guidance for navigating the hazards of embryonic
|SOURCE Global Information, Inc.|
Copyright©2010 PR Newswire.
All rights reserved